Institut D'investigació Biomèdica De Bellvitge
Clinical trials sponsored by Institut D'investigació Biomèdica De Bellvitge, explained in plain language.
-
One shot to stop HPV spread? new trial tests Vaccine's hidden power
Disease control Not yet recruitingThis phase 2 trial tests whether a single dose of the HPV vaccine (Gardasil-9) can reduce the infectivity of high-risk HPV in women aged 18-29 who already have the virus. Researchers will compare cervical samples from vaccinated and unvaccinated women at 6 months to see if vaccin…
Phase: PHASE2 • Sponsor: Institut d'Investigació Biomèdica de Bellvitge • Aim: Disease control
Last updated Jun 24, 2026 07:02 UTC
-
New sleep drug could ease both insomnia and depression
Symptom relief Not yet recruitingThis study tests whether daridorexant, a sleep medication, can help people who have both major depression and insomnia. Researchers want to see if it improves sleep quality and also eases depressive symptoms. About 134 adults will take either daridorexant or a placebo for three m…
Phase: PHASE4 • Sponsor: Institut d'Investigació Biomèdica de Bellvitge • Aim: Symptom relief
Last updated Jun 16, 2026 12:48 UTC